<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00535613</url>
  </required_header>
  <id_info>
    <org_study_id>H-2007-0069</org_study_id>
    <nct_id>NCT00535613</nct_id>
  </id_info>
  <brief_title>Propofol in Emergence Agitation</brief_title>
  <official_title>Does a Single Dose of Propofol Decrease the Incidence of Emergence Agitation in Children?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to see if a small dose of propofol given intravenously (through a&#xD;
      needle into a vein) at the end of anesthesia can make it less likely that children will be&#xD;
      agitated as the come out of the anesthetic.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Emergence agitation is defined as a mental disturbance during the recovery from general&#xD;
      anesthesia. It consists of confusion, disorientation, delusions, and hallucinations. It&#xD;
      manifests in children as some combination of restlessness, moaning, inconsolable crying,&#xD;
      involuntary physical activity, and thrashing about. This puts patients at risk of injuring&#xD;
      themselves or their caregivers, causing bleeding or disruption of their surgical repair, and&#xD;
      pulling out IVs and drains. It can be difficult to maintain necessary vital sign monitoring&#xD;
      in these agitated patients, and constant one-on-one nursing is often required. When emergence&#xD;
      agitation occurs, all members of the healthcare team, and the parents report dissatisfaction&#xD;
      with the quality of the child's recovery from anesthesia.&#xD;
&#xD;
      Propofol is a commonly used intravenous anesthetic agent. Studies have compared continuous&#xD;
      infusions of intravenous propofol versus inhalational sevoflurane for the maintenance of&#xD;
      anesthesia. These have shown a significant decrease in the incidence of emergence agitation&#xD;
      in the patients who received the propofol infusions. This proposed study will investigate the&#xD;
      effects of a single bolus dose of propofol at the conclusion of a sevoflurane inhalational&#xD;
      anesthetic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Emergent Agitation</measure>
    <time_frame>up to 30 min post surgery</time_frame>
    <description>Incidence of Emergent Agitation is defined as a Paediatric Anaesthesia Emergence Delirium (PAED) score above 10 at any point at the defined protocol time points (recovery, 5, 10, 15, 20, 25, or 30 minutes)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time Spent in Recovery Room</measure>
    <time_frame>up to 1 hour post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Received Medication in the Recovery Room</measure>
    <time_frame>up to 1 hour post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Emergence Agitation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>no propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 12 months to 6 years old&#xD;
&#xD;
          -  Planned surgery/procedure: The goal is to enroll patients who will not have pain when&#xD;
             they awake from anesthesia. We will include patients who are having magnetic resonance&#xD;
             imaging (MRI) under anesthesia, or an eye exam under anesthesia. We will also include&#xD;
             those patients who are having a surgery in which a regional or caudal block is part of&#xD;
             the planned anesthetic. This will be small orthopedic procedures in the lower&#xD;
             extremities; or urologic or general surgical procedures below the level of the&#xD;
             umbilicus. These patients have been chosen because the regional/caudal block should&#xD;
             result in the patient not having pain when they awake from anesthesia.&#xD;
&#xD;
        (The caudal block is a single epidural injection of local anesthetic that is done when the&#xD;
        pediatric patient is under general anesthesia. It is a routine procedure that results in&#xD;
        numbness below the level of the umbilicus, and gives relief of pain, for about 8 hours.)&#xD;
&#xD;
        Examples of orthopedic surgeries include, but are not limited to:&#xD;
&#xD;
        Removal of an extra digit or syndactyly repair Club foot releases Lower extremity tendon&#xD;
        releases or lengthenings Lower extremity tendon transfers Removal of hardware&#xD;
&#xD;
        Examples of urologic surgeries include, but are not limited to:&#xD;
&#xD;
        Circumcision or circumcision revision hypospadias repair Chordee repair Orchiopexy&#xD;
        Orchiectomy&#xD;
&#xD;
        Examples of general pediatric surgeries include, but are not limited to:&#xD;
&#xD;
        Inguinal hernia repair Rectal muscle biopsies Excision of lower extremity or lower&#xD;
        abdominal mass Burn scar releases and skin grafting&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Obstructive sleep apnea-Patients with sleep apnea are not ideal candidates for removal&#xD;
             of their endotracheal tube or laryngeal mask airway while still somewhat anesthetized.&#xD;
             It is preferable to extubate these patients awake.&#xD;
&#xD;
          -  Developmental delays-Patients with developmental delays may not interact with their&#xD;
             environment, make eye contact, have purposeful actions, or be aware of their&#xD;
             surroundings even when at their baseline pre-operatively. It would be difficult to&#xD;
             evaluate these features of emergence agitation in children who demonstrate this&#xD;
             behavior on a routine basis.&#xD;
&#xD;
          -  Psychological disorders-Patients with psychological disorders may have the same issues&#xD;
             as those with developmental delays when it comes to evaluating their behavior after&#xD;
             anesthesia.&#xD;
&#xD;
          -  Egg white allergy-Propofol is contraindicated in patients with egg white allergies due&#xD;
             to risk of allergy to the propofol lecithin base.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cari Meyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univeristy of Wisconsin - Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univeristy of Wisconsin - Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53726</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 23, 2007</study_first_submitted>
  <study_first_submitted_qc>September 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2007</study_first_posted>
  <results_first_submitted>September 20, 2019</results_first_submitted>
  <results_first_submitted_qc>September 20, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 9, 2019</results_first_posted>
  <last_update_submitted>October 8, 2019</last_update_submitted>
  <last_update_submitted_qc>October 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Propofol</title>
          <description>Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>No propofol</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Propofol</title>
          <description>Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>No propofol</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="99"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.88" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="B2" value="1.72" lower_limit="1" upper_limit="6"/>
                    <measurement group_id="B3" value="1.80" lower_limit="1" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Emergent Agitation</title>
        <description>Incidence of Emergent Agitation is defined as a Paediatric Anaesthesia Emergence Delirium (PAED) score above 10 at any point at the defined protocol time points (recovery, 5, 10, 15, 20, 25, or 30 minutes)</description>
        <time_frame>up to 30 min post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No propofol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Emergent Agitation</title>
          <description>Incidence of Emergent Agitation is defined as a Paediatric Anaesthesia Emergence Delirium (PAED) score above 10 at any point at the defined protocol time points (recovery, 5, 10, 15, 20, 25, or 30 minutes)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Spent in Recovery Room</title>
        <time_frame>up to 1 hour post surgery</time_frame>
        <population>The study team planned to collect post anesthesia care unit discharge time from the subject medical records, however PACU discharge time was often not recorded in routine cases during the study period. This was not anticipated by the study team and retrospective analysis was not possible for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No propofol</description>
          </group>
        </group_list>
        <measure>
          <title>Time Spent in Recovery Room</title>
          <population>The study team planned to collect post anesthesia care unit discharge time from the subject medical records, however PACU discharge time was often not recorded in routine cases during the study period. This was not anticipated by the study team and retrospective analysis was not possible for this outcome.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Received Medication in the Recovery Room</title>
        <time_frame>up to 1 hour post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No propofol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Received Medication in the Recovery Room</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 30 min post surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Propofol</title>
          <description>Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>No propofol</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Cari Meyer</name_or_title>
      <organization>University of Wisconsin</organization>
      <phone>(608) 265-5980</phone>
      <email>cmeyer@wisc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

